Notice
13 Mar 2025
compliance, healthcare, regulations, fda, food and drug administration, clinical practice
📋FDA Reopens Comment Period for Good Clinical Practice Guidance
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the draft guidance for industry entitled "E6(R3) Good Clinical Practice: Annex 2," announced in the Federal Register of December 30, 2024. The Agency is taking this action to allow interested persons additional time to submit comments.
Learn More